Patents by Inventor Harriet Rönnholm

Harriet Rönnholm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of neural stem cells and neural progenitor cells
    Patent number: 8318704
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via S1P or LPA signaling. These methods are useful for reducing at least one symptom of the disorder.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: November 27, 2012
    Assignee: NeuroNova AB
    Inventors: Per Lindquist, Alex Mercer, Harriet Rönnholm, Lilian Wikström
  • MODULATION OF NEURAL STEM CELLS AND NEURAL PROGENITOR CELLS
    Publication number: 20110189184
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via S1P or LPA signaling. These methods are useful for reducing at least one symptom of the disorder.
    Type: Application
    Filed: August 31, 2010
    Publication date: August 4, 2011
    Applicant: NeuroNova AB
    Inventors: Per Lindquist, Alex Mercer, Harriet Rönnholm, Lilian Wikström
  • Modulation of neural stem cells and neural progenitor cells
    Patent number: 7811822
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via S1P or LPA signaling. These methods are useful for reducing at least one symptom of the disorder.
    Type: Grant
    Filed: July 19, 2007
    Date of Patent: October 12, 2010
    Assignee: NeuroNova AB
    Inventors: Per Lindquist, Alex Mercer, Harriet Rönnholm, Lilian Wikström
  • Compounds and methods for increasing neurogenesis
    Patent number: 6969702
    Abstract: The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with neurogenesis increasing agents. Novel methods for treating neurological disorders using neurogenesis increasing agents are disclosed.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: November 29, 2005
    Assignee: NeuroNova AB
    Inventors: Göran Bertilsson, Rikard Erlandsson, Jonas Frisen, Anders Haegerstrand, Jessica Heidrich, Nina Hellström, Johan Häggblad, Katarina Jansson, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Karl Nyberg, Amina Ossoinak, Cesare Patrone, Harriet Rönnholm, Lilian Wikström, Olof Zachrisson